ABSTRACT
The state of chronic immune activation observed in many individuals with chronic fatigue syndrome (CFS) led to the first investigations of the status of the 2-5A/RNase L pathway in this syndrome. CFS is an illness of unknown etiology, associated with sudden onset, flu-like symptoms, debilitating fatigue, low-grade fever, myalgia, and neurocognitive dysfunction.
